These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12323065)

  • 1. Role of the azinomycin naphthoate and central amide in sequence-dependent DNA alkylation and cytotoxicity of epoxide-bearing substructures.
    Coleman RS; Burk CH; Navarro A; Brueggemeier RW; Diaz-Cruz ES
    Org Lett; 2002 Oct; 4(20):3545-8. PubMed ID: 12323065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azinomycin inspired bisepoxides: influence of linker structure on in vitro cytotoxicity and DNA interstrand cross-linking.
    LePla RC; Landreau CA; Shipman M; Hartley JA; Jones GD
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2861-4. PubMed ID: 15911269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding and alkylation by the "left half" of azinomycin B.
    Zang H; Gates KS
    Biochemistry; 2000 Dec; 39(48):14968-75. PubMed ID: 11101313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of DNA sequence selectivity and cell cytotoxicity on azinomycin A and B epoxyamide stereochemistry.
    Coleman RS; Woodward RL; Hayes AM; Crane EA; Artese A; Ortuso F; Alcaro S
    Org Lett; 2007 May; 9(10):1891-4. PubMed ID: 17432865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA cross-linking by azinomycin B: Monte Carlo simulations in the evaluation of sequence selectivity.
    Alcaro S; Ortuso F; Coleman RS
    J Med Chem; 2002 Feb; 45(4):861-70. PubMed ID: 11831897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis and cytotoxicity of some azinomycin analogues devoid of the 1-azabicyclo[3.1.0]hexane subunit.
    Hodgkinson TJ; Kelland LR; Shipman M; Suzenet F
    Bioorg Med Chem Lett; 2000 Feb; 10(3):239-41. PubMed ID: 10698444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of a DNA-crosslinking azinomycin analogue.
    Casely-Hayford MA; Pors K; James CH; Patterson LH; Hartley JA; Searcey M
    Org Biomol Chem; 2005 Oct; 3(19):3585-9. PubMed ID: 16172698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of action of azinomycin B: definition of regioselectivity and sequence selectivity of DNA cross-link formation and clarification of the role of the naphthoate.
    Coleman RS; Perez RJ; Burk CH; Navarro A
    J Am Chem Soc; 2002 Nov; 124(44):13008-17. PubMed ID: 12405827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling of DNA cross-linking analogues based on the azinomycin scaffold.
    Alcaro S; Ortuso F; Coleman RS
    J Chem Inf Model; 2005; 45(3):602-9. PubMed ID: 15921450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselectivity, sequence specificity and mechanism of action of the azinomycin epoxide.
    David-Cordonnier MH; Casely-Hayford M; Kouach M; Briand G; Patterson LH; Bailly C; Searcey M
    Chembiochem; 2006 Nov; 7(11):1658-61. PubMed ID: 16991169
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequence selectivity of azinomycin B in DNA alkylation and cross-linking: a QM/MM study.
    Senthilnathan D; Kalaiselvan A; Venuvanalingam P
    J Mol Model; 2013 Jan; 19(1):383-90. PubMed ID: 22930355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular model for DNA cross-linking by the antitumor agent azinomycin B.
    Alcaro S; Coleman RS
    J Med Chem; 2000 Jul; 43(15):2783-8. PubMed ID: 10956185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the molecular origin of the azinomycin epoxide: timing of the biosynthesis revealed.
    Sharma V; Kelly GT; Watanabe CM
    Org Lett; 2008 Nov; 10(21):4815-8. PubMed ID: 18841989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating noncovalent interactions between the azinomycins and double-stranded DNA: importance of the naphthalene substitution pattern on interstrand cross-linking efficiency.
    Landreau CA; LePla RC; Shipman M; Slawin AM; Hartley JA
    Org Lett; 2004 Sep; 6(20):3505-7. PubMed ID: 15387534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of a novel sequence-selective epoxide-containing DNA cross-linking agent based on the pyrrolo[2, 1-c][1,4]benzodiazepine system.
    Wilson SC; Howard PW; Forrow SM; Hartley JA; Adams LJ; Jenkins TC; Kelland LR; Thurston DE
    J Med Chem; 1999 Oct; 42(20):4028-41. PubMed ID: 10514273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of functional "top-half" partial structures of azinomycin a and B.
    Coleman RS; Tierney MT; Cortright SB; Carper DJ
    J Org Chem; 2007 Sep; 72(20):7726-35. PubMed ID: 17824658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking and sequence specific alkylation of DNA BY aziridinylquinones. 1. Quinone methides.
    Mayalarp SP; Hargreaves RH; Butler J; O'Hare CC; Hartley JA
    J Med Chem; 1996 Jan; 39(2):531-7. PubMed ID: 8558523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-selective DNA alkylation of GG steps by naphthaldiimide derivatives possessing enantiomeric epoxide.
    Okamoto A; Nakamura T; Yoshida K; Nakatani K; Saito I
    Org Lett; 2000 Oct; 2(21):3249-51. PubMed ID: 11029182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.